Dacryostenosis: Clinical Evaluation, Surgical Management and Long-Term Outcomes in a Prospective Cohort

Main Article Content

Juan Manuel Guerrero Fat
Ana Karen Altamirano Suárez
Diego Ochoa Díaz
Vania Bárbara Escobedo Sandoval
Saulo Emmanuel Gomez de Alba
Humberto Rodríguez Contreras

Abstract

Dacryostenosis, a chronic ophthalmologic condition characterized by partial or total obstruction of the lacrimal drainage system, has been the subject of in-depth scrutiny in the medical literature. This article aims to comprehensively investigate dacryostenosis from a clinical and surgical perspective, providing a comprehensive analysis of its etiology, clinical manifestations, and available treatment options.


Through a critical review of the current literature and presentation of data from a prospective cohort of patients, we explore state-of-the-art diagnostic modalities, such as magnetic resonance dacryocystography and optical coherence tomography, which have revolutionized the evaluation of dacryostenosis.


Regarding surgical management, traditional techniques, such as dacryocystorhinostomy, are discussed, together with the latest innovations, such as endoscopic dacryoplasty and intranasal balloon dilatation. A detailed comparison of the advantages and disadvantages of these techniques is presented, along with their success rates and associated complications.


Finally, long-term outcomes are examined, including improvement in patients' quality of life, symptom reduction, and durability of surgical interventions. This article provides a comprehensive view of dacryostenosis, highlighting the importance of a multidisciplinary approach to its management and the pivotal role of surgery in restoring tear function and ocular well-being.

Article Details

How to Cite
Juan Manuel Guerrero Fat, Ana Karen Altamirano Suárez, Diego Ochoa Díaz, Vania Bárbara Escobedo Sandoval, Saulo Emmanuel Gomez de Alba, & Humberto Rodríguez Contreras. (2023). Dacryostenosis: Clinical Evaluation, Surgical Management and Long-Term Outcomes in a Prospective Cohort. International Journal of Medical Science and Clinical Research Studies, 3(10), 2193–2197. https://doi.org/10.47191/ijmscrs/v3-i10-13
Section
Articles

References

I. Perez Y, Patel B, Mendez M. Nasolacrimal Duct Obstruction. E Treasure Island (FL): StatPearls Publishing; 2019. (Cited November 17, 2019) Available from:

https://www.ncbi.nlm.nih.gov/books/NBK532873/?report=classic

II. Dolar A. Mode of delivery, birth weight and the incidence of congenital nasolacrimal duct obstruction. Int J Ophthalmol. 2019; 12(7):1134-1138.

III. Davies R, Watkins W, Kotecha S, Watts P. The presentation, clinical features, complications, and treatment of congenital dacryocystocele. Eye. 2017; 32(3):522-526.

IV. Naranjo M, Macas C, Pacheco M, Piedrahita J. Nasolacrimal duct obstruction: endonasal versus external surgical approach. Recimundo. 2019; 3(3):509-26.

V. Vagge A, Ferro L, Nucci P, et al. Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review. Diseases. 2018; 6(96):1-11.

VI. Paysse E, Coats D. Congenital nasolacrimal duct obstruction (dacryostenosis) and dacryocystocele. Waltham, MA: UpToDate Inc; 2019. (Cited November 17, 2019) Available at: https://www.uptodate.com/contents/congenital-nasolacrimal-duct-obstruction-dacryostenosis-and-dacryocystocele.

VII. Saha B, Kumari R, Sinha B. Clinical Outcome of Probing in Infants with Acute Dacryocystitis - A Prospective Study. J Clin Diagn Res. 2017; 11(8):1-3.

VIII. Chong K, Abdulla H, Ali M. An update on endoscopic mechanical and powered dacryocystorhinostomy in acute dacryocystitis and lacrimal lacrimal abscess. Ann Anat. 2019; 2019:151408. doi: 10.1016/j.aanat.2019.07.009.

IX. Ali M. Pediatric Acute Dacryocystitis. Ophthal Plast Reconstr Surg. 2015; 31(5):341-347.

X. Chandra B, Kumari R, Prasanna B. Clinical outcome of probing in infants with acute Dacryocystitis - A Prospective Study. J Clin Diagn Res. 2017; 11(8):1-3.

XI. Valcheva K, Murgova S, Duhlenski B, Hristova I. Congenital nasolacrimal duct obstruction: epidemiology and risk factors. J of IMAB. 2019; 25(1):2317-2322.

XII. Sathiamoorthi S, Frank R, Mohney B. Incidence and clinical characteristics of congenital nasolacrimal duct obstruction. Br J Ophthalmol. 2019; 103(4):527- 529. doi: 10.1136/bjophthalmol-2018-312074.

XIII. Smaniotto A, Gazim C, Moreira H, Kormann B, Bezerra L. Congenital lacrimal obstruction: case series of probing and intubation. Rev bras oftalmol. 2016; 75(1):30-33.

XIV. Iqbal M, Sharif M. Comparison of nasolacrimal duct obstruction in pre-term and full-term infants. Ind J Pure App Biosci. 2019; 7(4):73-79.

XV. Assefa Y, Moges F, Endris M, et al. Bacteriological profile and drug susceptibility patterns in dacryocystitis patients attending Gondar University Teaching Hospital, Northwest Ethiopia. BMC Ophthalmol. 2015; 15(1):1-8.

XVI. Eslami F, Ghasemi H, Moradi A, Heidari S. Microbiological study of dacryocystitis in northwest of Iran. Clin Ophthalmol. 2018; 12: 1859-1864.

XVII. Rodriguez T, Vidal D. Anesthesia and Tetralogy of Fallot: case presentation. Rev Med Multimed. 2014; 18(1):1-12.

Most read articles by the same author(s)